Inducible Nitric Oxide Synthase and L-Arginine Optimizes Nitric Oxide Bioavailability in Ischemic Tissues Under Diabetes Mellitus Type 1.
Gazyakan, Emre
Inducible Nitric Oxide Synthase and L-Arginine Optimizes Nitric Oxide Bioavailability in Ischemic Tissues Under Diabetes Mellitus Type 1. [electronic resource] - Annals of plastic surgery 01 2020 - 106-112 p. digital
Publication Type: Journal Article
1536-3708
10.1097/SAP.0000000000002121 doi
Animals
Arginine--pharmacology
Biological Availability
Diabetes Mellitus, Type 1--metabolism
Male
Nitric Oxide--metabolism
Nitric Oxide Synthase Type II--pharmacology
Rats
Rats, Wistar
Reperfusion Injury--prevention & control
Inducible Nitric Oxide Synthase and L-Arginine Optimizes Nitric Oxide Bioavailability in Ischemic Tissues Under Diabetes Mellitus Type 1. [electronic resource] - Annals of plastic surgery 01 2020 - 106-112 p. digital
Publication Type: Journal Article
1536-3708
10.1097/SAP.0000000000002121 doi
Animals
Arginine--pharmacology
Biological Availability
Diabetes Mellitus, Type 1--metabolism
Male
Nitric Oxide--metabolism
Nitric Oxide Synthase Type II--pharmacology
Rats
Rats, Wistar
Reperfusion Injury--prevention & control